General
Nov. 29 News: Holiday travel, Alzheimer's blood test, COVID vaccine, Children's mental health
Spectrum News – Holiday travel may test the city’s contact tracing program
As New York City’s coronavirus infection rate continues to rise, the city’s contact tracing program is bracing for an even bigger surge after the Thanksgiving holiday.
Associated Press – First blood test to help diagnose Alzheimer’s goes on sale
A company has started selling the first blood test to help diagnose Alzheimer’s disease, a leap for the field that could make it much easier for people to learn whether they have dementia. It also raises concern about the accuracy and impact of such life-altering news.
Associated Press – Moderna asking US, European regulators to OK its virus shots
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.
NPR – Canada blocks export of medications in short supply in response to Trump plan
Ahead of an expected surge in U.S. demand for prescription drugs, the Canadian government has blocked the distribution of certain medications outside Canada in order to avoid a shortage within the country.
NPR – Pandemic takes toll on children's mental health
As a toddler, Kenley Gupta stopped speaking after her mom died. Over the years, she recovered from the anxiety disorder, called mutism, but in March the 8-year-old went silent again.
As Walter Veal cared for residents at the Ludeman Developmental Center in suburban Chicago, he saw the potential future of his grandson, who has autism.
